Literature DB >> 2854444

Reduced short-term neuropsychological performance in patients with nonsmall-cell lung cancer treated with cisplatin and etoposide.

S Kaasa1, B T Olsnes, E Thorud, H Høst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854444     DOI: 10.1159/000416209

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


× No keyword cloud information.
  5 in total

1.  Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?

Authors:  Fay J Hlubocky; Greg A Sachs; Eric R Larson; Halla S Nimeiri; David Cella; Kristen E Wroblewski; Mark J Ratain; Jeffery M Peppercorn; Christopher K Daugherty
Journal:  J Clin Oncol       Date:  2018-07-09       Impact factor: 44.544

2.  Cognitive and brain structural changes in a lung cancer population.

Authors:  Marta Simó; James C Root; Lucía Vaquero; Pablo Ripollés; Josep Jové; Tim Ahles; Arturo Navarro; Felipe Cardenal; Jordi Bruna; Antoni Rodríguez-Fornells
Journal:  J Thorac Oncol       Date:  2015-01       Impact factor: 15.609

3.  D-methionine protects against cisplatin-induced neurotoxicity in the hippocampus of the adult rat.

Authors:  Sneha Hinduja; Kari Suzanne Kraus; Senthilvelan Manohar; Richard J Salvi
Journal:  Neurotox Res       Date:  2014-12-09       Impact factor: 3.911

4.  Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes.

Authors:  Senthilvelan Manohar; Samson Jamesdaniel; Richard Salvi
Journal:  Neurotox Res       Date:  2013-11-26       Impact factor: 3.911

5.  Aberrant static and dynamic functional connectivity of the executive control network in lung cancer patients after chemotherapy: a longitudinal fMRI study.

Authors:  Lanyue Hu; Huiyou Chen; Wen Su; Yujie Zhang; Jia You; Wei Gu; Zhenyu Xiong; Xindao Yin; Yu-Chen Chen
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.